1,546
Views
0
CrossRef citations to date
0
Altmetric
Article

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice

ORCID Icon, , , , , , , , , , & show all
Article: 2186728 | Received 23 Jan 2023, Accepted 27 Feb 2023, Published online: 13 Mar 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.